文献速递消化道肿瘤与早癌

可变剪接的遗传调控及其在结直肠癌机制中的独特作用

Genetic Control of Alternative Splicing and its Distinct Role in Colorectal Cancer Mechanisms.
PubMed 文献 · Gastroenterology · 2023-08-03

研究对33种癌症进行剪接数量性状位点(sQTL)分析,并在154例结直肠癌组织中验证,通过大规模多中心多种族病例对照研究(34,585例病例和76,023例对照)发现sQTL rs61746794-T与中国人群结直肠癌风险升高相关(OR 1.20),与欧洲人群风险升高相关(OR 1.11),并揭示其通过PRPF8介导PRMT7外显子16剪接促进结直肠癌生长的机制。

要点

  • sQTL rs61746794-T与中国人群结直肠癌风险升高相关(OR 1.20,95%CI 1.12-1.29)。
  • rs61746794-T与欧洲人群结直肠癌风险升高相关(OR 1.11,95%CI 1.07-1.16)。
  • rs61746794-T通过PRPF8介导PRMT7外显子16剪接,增加PRMT7-V2水平促进结直肠癌生长。

核心结论

  • 研究提供了信息丰富的sQTL资源,并揭示剪接变异与癌症风险相关的调控机制,可作为生物标志物和治疗靶点。

研究设计与样本

  • 基于癌症基因组图谱(TCGA)33种癌症类型的sQTL分析,并在本研究的154例结直肠癌组织中独立验证。
  • 大规模多中心多种族病例对照研究纳入34,585例病例和76,023例对照,检验sQTL与结直肠癌风险的关联。
  • 进行一系列体外和体内生物学实验探究候选sQTL及靶基因的潜在机制。

主要发现

  • sQTL的分子特征揭示其在癌症易感性中的独特作用,肿瘤特异性sQTL对癌症发展显示出更好的响应。
  • 功能信息整合的多基因风险评分突显sQTL在结直肠癌预测中的潜力。
  • rs61746794-T与中国人群结直肠癌风险升高相关(OR 1.20,95%CI 1.12-1.29,P=8.82×10-7),与欧洲人群风险升高相关(OR 1.11,95%CI 1.07-1.16,P=1.13×10-7)。
  • rs61746794-T促进由RNA结合蛋白PRPF8介导的PRMT7外显子16剪接,增加经典PRMT7异构体(PRMT7-V2)水平。
  • 过表达PRMT7-V2较PRMT7-V1显著增强结直肠癌细胞和异种移植肿瘤的生长。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Dysregulation of alternative splicing is implicated in many human diseases, and understanding the genetic variation underlying transcript splicing is essential to dissect the molecular mechanisms of cancers. We aimed to provide a comprehensive functional dissection of splicing quantitative trait loci (sQTLs) in cancer and focus on elucidating its distinct role in colorectal cancer (CRC) mechanisms. METHODS: We performed a comprehensive sQTL analysis to identify genetic variants that control messenger RNA splicing across 33 cancer types from The Cancer Genome Atlas and independently validated in our 154 CRC tissues. Then, large-scale, multicenter, multi-ethnic case-control studies (34,585 cases and 76,023 controls) were conducted to examine the association of these sQTLs with CRC risk. A series of biological experiments in vitro and in vivo were performed to investigate the potential mechanisms of the candidate sQTLs and target genes. RESULTS: The molecular characterization of sQTL revealed its distinct role in cancer susceptibility. Tumor-specific sQTL further showed better response to cancer development. In addition, functionally informed polygenic risk score highlighted the potentiality of sQTLs in the CRC prediction. Complemented by large-scale population studies, we identified that the risk allele (T) of a multi-ancestry-associated sQTL rs61746794 significantly increased the risk of CRC in Chinese (odds ratio, 1.20; 95% CI, 1.12-1.29; P = 8.82 × 10-7) and European (odds ratio, 1.11; 95% CI, 1.07-1.16; P = 1.13 × 10-7) populations. rs61746794-T facilitated PRMT7 exon 16 splicing mediated by the RNA-binding protein PRPF8, thus increasing the level of canonical PRMT7 isoform (PRMT7-V2). Overexpression of PRMT7-V2 significantly enhanced the growth of CRC cells and xenograft tumors compared with PRMT7-V1. Mechanistically, PRMT7-V2 functions as an epigenetic writer that catalyzes the arginine methylation of H4R3 and H3R2, subsequently regulating diverse biological processes, including YAP, AKT, and KRAS pathway. A selective PRMT7 inhibitor, SGC3027, exhibited antitumor effects on human CRC cells. CONCLUSIONS: Our study provides an informative sQTLs resource and insights into the regulatory mechanisms linking splicing variants to cancer risk and serving as biomarkers and therapeutic targets.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Zhang M, Chen C, Lu Z, et al. Genetic Control of Alternative Splicing and its Distinct Role in Colorectal Cancer Mechanisms. Gastroenterology. 2023. PMID: 37541527. doi:10.1053/j.gastro.2023.07.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。